Published in Ann Rheum Dis on January 01, 1990
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
HLA antigens in psoriatic arthritis. J Rheumatol (1986) 1.69
"Rheumatoid arthritis" with negative serological reaction. Ann Rheum Dis (1960) 1.55
Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med (1983) 1.48
Treatment of psoriasis with azathioprine. Br Med J (1974) 1.34
Psoriatic arthritis: clinical subgroups and histocompatibility antigens. Ann Rheum Dis (1987) 1.06
Erosive osteoarthritis and psoriatic arthritis: a radiologic comparison in the hand, wrist, and foot. AJR Am J Roentgenol (1980) 0.96
Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93
Radiologic comparison of erosive polyarthritides with prominent interphalangeal involvement. Skeletal Radiol (1982) 0.84
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet (1997) 6.71
Increased risk of developing ankylosing spondylitis among first-born children. Arthritis Rheum (2000) 2.76
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (1996) 2.30
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2001) 2.11
Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol (1998) 2.09
Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07
Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum (2001) 1.84
Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis (1997) 1.83
Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis (1998) 1.72
Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol (1997) 1.63
Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet (1998) 1.60
Sleep apnoea caused by rheumatoid arthritis. Br J Rheumatol (1998) 1.49
Tenosynovitis due to Mycobacterium avium-intracellulare: case report and a review of the literature. Clin Exp Rheumatol (1992) 1.48
Magnetic resonance imaging of the shoulder in patients with rheumatoid arthritis. Ann Rheum Dis (1990) 1.48
Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol (1992) 1.46
Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy. J Rheumatol (1995) 1.45
Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy. J Rheumatol (1996) 1.40
Ferritin and serum transferrin receptor predict iron deficiency in anemic patients with rheumatoid arthritis. Arthritis Rheum (2001) 1.39
Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol (1994) 1.39
Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Arch Dermatol (1997) 1.39
[Pharmacotherapy of patients with (early) rheumatoid arthritis]. Ned Tijdschr Geneeskd (2000) 1.39
[Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs]. Ned Tijdschr Geneeskd (1999) 1.39
Antibiotics as disease modifiers in arthritis. Clin Exp Rheumatol (1993) 1.38
Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br J Rheumatol (1998) 1.38
Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis (2001) 1.34
Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum (1990) 1.33
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum (1994) 1.24
Predictors of functional status in patients with early rheumatoid arthritis. Ann Rheum Dis (2000) 1.21
Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients. Ann Rheum Dis (2011) 1.20
Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial. Arthritis Rheum (1996) 1.19
The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob Agents Chemother (1996) 1.18
Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum (1988) 1.18
Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis (2000) 1.18
Assessment of shoulder function in rheumatoid arthritis. J Rheumatol (1996) 1.17
Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. Ann Rheum Dis (1986) 1.15
The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clin Exp Rheumatol (1993) 1.13
Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis. J Rheumatol (1990) 1.12
A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum (1995) 1.10
Total knee arthroplasty infection due to Gemella haemolysans. Br J Rheumatol (1992) 1.07
Non-gonococcal infectious arthritis: a retrospective study. J Infect (1987) 1.07
The cervical spine in rheumatoid arthritis: relationship between neurologic signs and morphology of MR imaging and radiographs. Skeletal Radiol (1996) 1.05
Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum (1998) 1.05
No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis Rheum (1998) 1.03
The influence of tetracyclines on T cell activation. Clin Exp Immunol (1995) 1.03
Greater trochanteric pain syndrome (trochanteric bursitis) in low back pain. Scand J Rheumatol (1991) 1.03
Longterm cyclosporine therapy in rheumatoid arthritis. J Rheumatol (1991) 1.01
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet (2000) 1.01
Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study. J Rheumatol (1994) 1.00
Infectious arthritis caused by Propionibacterium acnes: a report of two cases. Ann Rheum Dis (1989) 0.99
An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Ann Rheum Dis (1996) 0.98
Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold. Ann Rheum Dis (1992) 0.98
Minocycline treatment for rheumatoid arthritis: an open dose finding study. J Rheumatol (1990) 0.97
Comparison of high and low intensity training in well controlled rheumatoid arthritis. Results of a randomised clinical trial. Ann Rheum Dis (1996) 0.96
Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis. Ann Rheum Dis (2000) 0.96
Androgens and ankylosing spondylitis: a role in the pathogenesis? Ann N Y Acad Sci (1999) 0.94
Oral contraceptives and the risk of rheumatoid arthritis: the great transatlantic divide? Br J Rheumatol (1989) 0.94
Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Thromb Haemost (1992) 0.94
Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis (1987) 0.93
The effect of co-trimoxazole on serum creatinine. Br J Clin Pharmacol (1981) 0.93
Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation. Ann Rheum Dis (1997) 0.92
Plasminogen activators in synovial fluid and plasma from patients with arthritis. Ann Rheum Dis (1992) 0.92
Bone metabolism in rheumatoid arthritis; relation to disease activity. Br J Rheumatol (1993) 0.92
Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology (Oxford) (1999) 0.91
The association of Sweet's syndrome with sarcoidosis. Neth J Med (2001) 0.91
Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. Arthritis Rheum (1995) 0.90
Bone mineral density in ambulant, non-steroid treated female patients with rheumatoid arthritis. Clin Exp Rheumatol (1993) 0.90
Heart conduction disturbance: an HLA-B27 associated disease. Ann Rheum Dis (1991) 0.89
Effect of bacterial competition on the opsonization, phagocytosis, and intracellular killing of microorganisms by granulocytes. Infect Immun (1985) 0.89
Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use. Arthritis Rheum (1990) 0.89
A clinical epidemiological study in low back pain. Description of two clinical syndromes. Br J Rheumatol (1990) 0.89
A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum (1994) 0.89
Brain abscess due to Streptobacillus moniliformis and Actinobacterium meyerii. Infection (1984) 0.89
A gastroscopic study of the predictive value of risk factors for non-steroidal anti-inflammatory drug-associated ulcer disease in rheumatoid arthritis patients. Br J Rheumatol (1994) 0.88
The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol (1996) 0.88
Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clin Exp Rheumatol (1998) 0.88
Neurologic dysfunction in patients with rheumatoid arthritis of the cervical spine. Predictive value of clinical, radiographic and MR imaging parameters. Eur Radiol (2001) 0.87
Outcome of cervical spine surgery in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 0.87
Discordance between objective and subjective assessment of functional ability of patients with rheumatoid arthritis. Br J Rheumatol (1995) 0.86
Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 0.86
Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study. J Rheumatol (1991) 0.85
Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol (2000) 0.85
Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritis. J Rheumatol (1992) 0.85
Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum (1990) 0.85
Increased prevalence of spondylarthropathies in parents of children with pauciarticular juvenile chronic arthritis, type 1. Clin Rheumatol (1993) 0.85
Sepsis syndrome and death after bronchoalveolar lavage. Chest (1993) 0.85
Gonadal and adrenal sex steroids in ankylosing spondylitis. Rheum Dis Clin North Am (2000) 0.84
Antibiotic prophylaxis in craniotomy: a prospective double-blind placebo-controlled study. Scand J Infect Dis (1988) 0.84
Oral contraceptive treatment for rheumatoid arthritis: an open study in 10 female patients. Br J Rheumatol (1989) 0.84
Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis. Scand J Rheumatol (2001) 0.83
Fumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled study. Br J Rheumatol (1992) 0.82
Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. J Rheumatol (1998) 0.82
The pharmacokinetics of metronidazole and tinidazole in patients with mixed aerobic--anaerobic infections. J Antimicrob Chemother (1982) 0.82
No effect of intramuscular gold therapy on serological parameters of Helicobacter pylori infection in patients with rheumatoid arthritis: a 12 month prospective study. Ann Rheum Dis (1994) 0.82
Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry. Arthritis Rheum (1996) 0.82
The limited value of the Health Assessment Questionnaire as an outcome measure in short term exercise trials. J Rheumatol (1997) 0.82
Sjögren's syndrome: an unusual cause of Bell's palsy. Ann Rheum Dis (2001) 0.82
Cyclosporine in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis. J Rheumatol (1994) 0.81
Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss. Rheumatology (Oxford) (1999) 0.81
Combination therapy in rheumatoid arthritis. Curr Opin Rheumatol (2001) 0.81
Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. Rheumatology (Oxford) (2000) 0.81